Dierks follows Walz as NuPharm’s chief

NuPharm has appointed former Meda chief executive officer (CEO) Jörg-Thomas Dierks to become CEO of the European central nervous system (CNS) specialist, replacing with immediate effect Stephan Walz, who has “decided to step down in order to pursue other activities”.

More from Leadership

More from Generics Bulletin